Loading institutional data...
Loading institutional data...
Held by 353 of 5,944 reporting institutions (95th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
No trend data available for this metric.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.18B 100.0% | $3.33B 100.0% | $2.56B 100.0% | $1.99B 100.0% | $1.37B 100.0% | $766.9M 100.0% | $731.4M 100.0% | $560.6M 100.0% |
| Cost of Revenue | — | — | — | — | $1.09B 79.6% | $589.1M 76.8% | $558.0M 76.3% | $419.9M 74.9% |
| Gross Profit | — | — | — | — | $278.4M 20.4% | $177.8M 23.2% | $173.4M 23.7% | $140.7M 25.1% |
| Research & Development | $6.0M 0.1% | $4.0M 0.1% | $1.0M 0.0% | $500K 0.0% | $1.8M 0.1% | $1.2M 0.2% | $1.6M 0.2% | $1.6M 0.3% |
| Selling, General & Admin | $682.0M 16.3% | $459.0M 13.8% | $329.0M 12.8% | $267.4M 13.4% | $219.5M 16.1% | $186.5M 24.3% | $117.1M 16.0% | $79.8M 14.2% |
| Total Operating Expenses | — | — | — | — | $327.6M 24.0% | $235.4M 30.7% | $177.8M 24.3% | $153.8M 27.4% |
| Operating Income | $351.0M 8.4% | $247.0M 7.4% | $115.0M 4.5% | $94.7M 4.8% | -$49.2M -3.6% | -$57.6M -7.5% | -$4.4M -0.6% | -$13.1M -2.3% |
| Interest Expense | $190.0M 4.5% | $62.0M 1.9% | $32.1M 1.3% | $32.5M 1.6% | $28.0M 2.0% | $40.2M 5.2% | $51.5M 7.0% | $47.0M 8.4% |
| Interest & Investment Income | $59.0M 1.4% | $34.0M 1.0% | $32.0M 1.2% | $10.8M 0.5% | $0 0.0% | $0 0.0% | — | — |
| Other Income (Expense), net | -$9.0M -0.2% | $2.0M 0.1% | -$4.0M -0.2% | $500K 0.0% | $100K 0.0% | $600K 0.1% | $1.0M 0.1% | $600K 0.1% |
| Pretax Income | $195.0M 4.7% | -$1.0M -0.0% | $120.0M 4.7% | $86.9M 4.4% | -$77.1M -5.6% | -$113.8M -14.8% | -$54.9M -7.5% | -$59.5M -10.6% |
| Income Tax Expense | $48.0M 1.1% | -$296.0M -8.9% | -$3.0M -0.1% | $200K 0.0% | -$3.1M -0.2% | -$2.4M -0.3% | $1.7M 0.2% | -$4.1M -0.7% |
| Net Income | $147.0M 3.5% | $294.5M 8.8% | $122.9M 4.8% | $86.7M 4.3% | -$48.2M -3.5% | -$18.4M -2.4% | -$56.6M -7.7% | -$55.4M -9.9% |
| Per Share | ||||||||
| Weighted Avg Shares (Basic) | 1.3M | 1.7M | 1.9M | 3.9M | — | — | — | — |
| Weighted Avg Shares (Diluted) | 1.3M | 1.7M | 1.9M | 3.9M | — | — | — | — |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
5/8 of the 9 checks — 1 couldn't be scored (see above), so the score is out of the 8 with data.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81 · book equity (no price)
Needs granular two-year detail (receivables, PP&E, D&A, SG&A) — not fully reported.
Earnings are backed by cash (FCF ≥ net income) — high quality. Lower/negative accruals = higher quality (Sloan).
Interest coverage is thin — monitor; leverage rising year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $453M buybacks = $453M returned on $624M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 8 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Modest payoff on reinvested capital. Current ROIC on all capital: 2%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 8 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $964M covers the $7M due within a year 137.7× over. Scheduled principal only (excludes interest & revolver draws). As of 2026-03-31 (10-Q).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Thin coverage — earnings barely cover interest. Effective rate ~4.2% on $4.5B of debt.
Cash of $964M fully covers short-term debt of $10M.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
No current price collected.
Where each multiple sits in its own 6-yr range
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 6-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 1.7× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 74.9 | 76.3 | 76.8 | 79.6 | — | — | — | — |
| Gross Profit | 25.1 | 23.7 | 23.2 | 20.4 | — | — | — | — |
| R&D | 0.3 | 0.2 | 0.2 | 0.1 | 0.0 | 0.0 | 0.1 | 0.1 |
| SG&A | 14.2 | 16.0 | 24.3 | 16.1 | 13.4 | 12.8 | 13.8 | 16.3 |
| Operating Income | -2.3 | -0.6 | -7.5 | -3.6 | 4.8 | 4.5 | 7.4 | 8.4 |
| Income Tax | -0.7 | 0.2 | -0.3 | -0.2 | 0.0 | -0.1 | -8.9 | 1.1 |
| Net Income | -9.9 | -7.7 | -2.4 | -3.5 | 4.3 | 4.8 | 8.8 | 3.5 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on FOUR: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.